News
REGEN-COV Antibody Cocktail Is Active Against SARS-CoV-2 Variants First Identified in the UK and South Africa
Regeneron Pharmaceuticals, Inc. announced that researchers in Dr. David Ho's Columbia University lab and Regeneron scientists have independently confirmed that REGEN-COVTM (casirivimab and imdevimab antibody cocktail) successfully neutralizes the circulating SARS-CoV-2 variants first identified in the UK (B.1.1.7) and...
News
COVID-19 Vaccine AstraZeneca authorised for use in the EU
AstraZeneca’s COVID-19 vaccine has been granted a conditional marketing authorisation (CMA) in the EU for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older.
Following review of the application, the Committee for Medicinal...
News
Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research
Lonza has expanded its renowned human primary cell offerings with the launch of fully customizable, high-quality cryopreserved Leukopaks. The frozen Leukopaks will enable long-distance shipping of leukapheresis products without the concern of reduced cell viability encountered with fresh Leukopaks....
News
Exothera expands range of state-of-the-art technologies by acquiring the NevoLine Upstream platform for Belgium site
Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO) delivering customized process development and GMP (Good Manufacturing Practices) manufacturing services for gene therapy and viral vector-based vaccines, announces that it has acquired the NevoLine™ Upstream manufacturing platform, the...
News
The Pistoia Alliance Launches Its Enhanced President’s Startup Challenge
The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life science and healthcare R&D, has launched its revised President’s Startup Challenge. Building on the success of the previous six years, 2021 will see...
News
Prime Global and Raremark form strategic partnership to transform solutions and outcomes for patients with rare diseases
Medical communications company, Prime Global, and healthcare technology company, Raremark®, announced that they have formed a strategic partnership to transform solutions for patients with rare diseases. Together, the companies will uncover insights into the entire patient journey that will...
News
Elasmogen identifies potential vaccine candidates to fight Covid-19
Elasmogen Ltd, the pioneering biopharmaceutical company leading the development of VNAR and soloMERTM biologics, announces a significant breakthrough in the identification of next-generation protein-based drugs potentially capable of stopping Covid-19 infections. This new approach has been achieved through a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















